Surgery Branch
Tumor Immunology Section
Investigator

National Cancer Institute
9000 Rockville Pike
Building 10, Room 12N238, MSC 1908
Bethesda, MD 20892

Phone: 301-402-0083
Fax: 301-496-0734
avitali@mail.nih.gov

Dr. Avital graduated from the New York University School of Medicine and completed his general surgery residency at the Cedars-Sinai Medical Center, UCLA, as well as a 3-year research fellowship in liver regeneration, bioartificial liver, and liver stem cells in the Bioartificial Liver Support Laboratory at Cedars-Sinai Medical Center. Following completion of his general surgery residency at Cedars-Sinai Medical Center, Dr. Avital completed two clinical fellowships in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center in New York. Subsequently he was appointed to the Surgery Branch at the National Cancer Institute, NIH. He received NIH tenure track in 2006 and was appointed assistant professor of surgery with the Uniformed Services University of the Health Sciences in 2009. His clinical interests include surgical management of complex diffuse metastatic malignancies; in particular, colorectal, liver, pancreatic, gastric, and breast metastatic cancers. His translational research efforts are focused on generating novel cancer treatments based on targeting solid organ cancer stem cells.

Dr. Avital's Clinical Trial(s):

NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with solid tumor or pancreatic cancer. Click on the trial(s) below for additional details, including a summary of eligibility criteria, study outline, and information on how to contact the study team directly.

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial NCI-09-C-0189

The Natural History of Solid Organ Cancer Stem Cells NCI-09-C-0079

Pancreas Resection for the Procurement of Tissue in Patients With Suspected Pancreas Malignancy NCI-05-C-0044